Blood and urine tests to study heart risk in kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks for new markers in blood or urine that may help explain heart (cardiovascular) risk in people with chronic kidney disease. It may help doctors better predict risk, especially in those not yet on dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must sign a written consent form to join
- You have chronic kidney disease but you are not on dialysis
- Your kidney function is described by a lab measure called GFR (glomerular filtration rate)
- You cannot be pregnant
- You must not need dialysis treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at heart (cardiovascular) risk factors in people who are just starting dialysis for chronic kidney failure. It may help doctors better understand what heart-related issues to watch for early during dialysis.
This study looks at whether a simple blood test can predict if calcium will build up in the heart's arteries in people with advanced kidney disease. The goal is to help doctors better monitor heart health in these patients.
This study is looking at the link between kidney disease and heart disease. It aims to understand how heart problems affect people with chronic kidney disease. The trial does not test a new drug, but rather follows patients to learn more about their health.
This study tests a new approach to protect the heart and kidneys in people with both chronic kidney disease and heart or blood vessel problems. By optimising treatment, researchers hope to reduce the risk of further kidney or heart damage.
This study looks at how a protein called FGF23, which helps control minerals in your body, changes as kidney disease progresses. By understanding this, doctors may find better ways to manage kidney disease.
This trial tests whether a blood test looking at platelets and tiny cell particles can help predict future blood clots or bleeding in people who have both chronic kidney disease and a recent heart attack. The goal is to improve treatment safety.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.